nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of Multicategory Exposure Marginal Structural Models to Investigate the Association between Long-Acting Beta-Agonists and Prescribing of Oral Corticosteroids for Asthma Exacerbations in the Clinical Practice Research Datalink
|
Ali, Ayad K. |
|
2015 |
18 |
2 |
p. 260-270 11 p. |
artikel |
2 |
A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I: Descriptive Characteristics
|
Janssens, Astrid |
|
2015 |
18 |
2 |
p. 315-333 19 p. |
artikel |
3 |
A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part II: Evaluation of Psychometric Performance of English-Language Versions in a General Population
|
Janssens, Astrid |
|
2015 |
18 |
2 |
p. 334-345 12 p. |
artikel |
4 |
A Unified Framework for Classification of Methods for Benefit-Risk Assessment
|
Najafzadeh, Mehdi |
|
2015 |
18 |
2 |
p. 250-259 10 p. |
artikel |
5 |
Clinical Trials Provide Essential Evidence, but Rarely Offer a Vehicle for Cost-Effectiveness Analysis
|
Sculpher, Mark |
|
2015 |
18 |
2 |
p. 141-142 2 p. |
artikel |
6 |
Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicular Lymphoma
|
Chen, Qiushi |
|
2015 |
18 |
2 |
p. 189-197 9 p. |
artikel |
7 |
Copyright/Subscription
|
|
|
2015 |
18 |
2 |
p. iv- 1 p. |
artikel |
8 |
Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report
|
Ramsey, Scott D. |
|
2015 |
18 |
2 |
p. 161-172 12 p. |
artikel |
9 |
Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence
|
Zhong, Yue |
|
2015 |
18 |
2 |
p. 308-314 7 p. |
artikel |
10 |
Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials
|
Cope, Shannon |
|
2015 |
18 |
2 |
p. 234-249 16 p. |
artikel |
11 |
Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”: A Novel Measure for Cost-Containment of Drug Expenditure
|
Garattini, Livio |
|
2015 |
18 |
2 |
p. 352- 1 p. |
artikel |
12 |
Dynamic Simulation in Health Care Comes of Age
|
Roberts, Mark S. |
|
2015 |
18 |
2 |
p. 143-144 2 p. |
artikel |
13 |
Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis
|
Carlson, Josh J. |
|
2015 |
18 |
2 |
p. 173-179 7 p. |
artikel |
14 |
Editorial Board
|
|
|
2015 |
18 |
2 |
p. IFC- 1 p. |
artikel |
15 |
Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment
|
Ayyagari, Rajeev |
|
2015 |
18 |
2 |
p. 198-205 8 p. |
artikel |
16 |
Erratum
|
|
|
2015 |
18 |
2 |
p. 353- 1 p. |
artikel |
17 |
Erratum
|
|
|
2015 |
18 |
2 |
p. 353- 1 p. |
artikel |
18 |
Erratum
|
|
|
2015 |
18 |
2 |
p. 353- 1 p. |
artikel |
19 |
Fairness versus Efficiency of Vaccine Allocation Strategies
|
Yi, Ming |
|
2015 |
18 |
2 |
p. 278-283 6 p. |
artikel |
20 |
Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes: A Comparison of Sample Size Requirements for an Incontinence Treatment Trial
|
Halme, Alex S. |
|
2015 |
18 |
2 |
p. 292-298 7 p. |
artikel |
21 |
Instructions for Authors
|
|
|
2015 |
18 |
2 |
p. I-II nvt p. |
artikel |
22 |
Learning and Satisficing: An Analysis of Sequence Effects in Health Valuation
|
Craig, Benjamin M. |
|
2015 |
18 |
2 |
p. 217-223 7 p. |
artikel |
23 |
Mapping the Clinical Chronic Obstructive Pulmonary Disease Questionnaire onto Generic Preference-Based EQ-5D Values
|
Boland, Melinde R.S. |
|
2015 |
18 |
2 |
p. 299-307 9 p. |
artikel |
24 |
Merging Regulatory and Reimbursement Needs in Clinical Trials
|
Cook, John R. |
|
2015 |
18 |
2 |
p. 145-146 2 p. |
artikel |
25 |
Need for Multicriteria Evaluation of Generic Drug Policies
|
Kaló, Zoltán |
|
2015 |
18 |
2 |
p. 346-351 6 p. |
artikel |
26 |
Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions
|
Crown, William H. |
|
2015 |
18 |
2 |
p. 137-140 4 p. |
artikel |
27 |
Predictors of Self-Reported Adherence to Antihypertensive Medicines: A Multinational, Cross-Sectional Survey
|
Morrison, Valerie L. |
|
2015 |
18 |
2 |
p. 206-216 11 p. |
artikel |
28 |
Public Preferences for Prioritizing Preventive and Curative Health Care Interventions: A Discrete Choice Experiment
|
Luyten, Jeroen |
|
2015 |
18 |
2 |
p. 224-233 10 p. |
artikel |
29 |
Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force
|
Marshall, Deborah A. |
|
2015 |
18 |
2 |
p. 147-160 14 p. |
artikel |
30 |
Strengthening Tuberculosis Control Overseas: Who Benefits?
|
Nguyen, Hoa Thi Minh |
|
2015 |
18 |
2 |
p. 180-188 9 p. |
artikel |
31 |
Table of Contents
|
|
|
2015 |
18 |
2 |
p. i-iii nvt p. |
artikel |
32 |
The Changing Face of the Cost-Utility Literature, 1990–2012
|
Neumann, Peter J. |
|
2015 |
18 |
2 |
p. 271-277 7 p. |
artikel |
33 |
Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013
|
Charokopou, Mata |
|
2015 |
18 |
2 |
p. 284-291 8 p. |
artikel |